Fziomed, Inc. Showcases Innovative Adhesion Barrier Solutions
Fziomed, Inc. is set to participate in the 2025 IFSSH and IFSHT Triennial Global Hand Congress, showcasing its cutting-edge adhesion barrier gel products designed to enhance postoperative recovery. The congress will be held from March 24-28, highlighting advancements in hand surgery and related therapies. Fziomed's presence at this prestigious event underscores its commitment to improving surgical outcomes through innovative solutions.
Introducing Dynavisc Adhesion Barrier Gel
At the forefront of Fziomed's offerings is Dynavisc, an adhesion barrier gel utilizing a unique synthetic dual-polymer technology. This innovative product is designed specifically to minimize adhesion formation following tendon and peripheral nerve surgeries. By creating a temporary physical barrier between tissues, Dynavisc significantly reduces the likelihood of complications associated with adhesions, such as postoperative pain and restricted movement.
The Clinical Advantage of Dynavisc
With over two decades of clinical experience, Fziomed's adhesion barrier products have been extensively studied and trusted by healthcare professionals. Dynavisc not only facilitates ease of application but also boasts a simple applicator, which is critical for ensuring safe and effective use during surgical procedures. Healthcare providers can confidently employ this solution, knowing it has demonstrated safety and clinical efficacy.
The Importance of Preventing Postoperative Adhesions
Postoperative adhesions can develop despite the best surgical techniques. Conditions such as flexor tendon repair and neurolysis are particularly prone to adhesion formation. Dr. Gere diZerega, Fziomed's Medical Director, emphasizes the importance of safeguarding patients through the application of Dynavisc. The gel's ability to create a barrier is crucial in protecting patients and maximizing the benefits of their surgical procedures.
Feedback from the CEO
Paul Mraz, CEO of Fziomed, expressed enthusiasm for the company’s innovative products, stating, "Our synthetic, absorbable gels are developed to enhance surgical precision while ensuring better patient outcomes. We strive to equip surgeons with technology that complements their expertise without adding complexity to procedures." His insight reflects Fziomed's dedication to quality and innovation in medical technology.
Ease of Use and Accessibility
Fziomed's products are designed for immediate use right out of the package. The sterile gels come with specialized applicators that facilitate straightforward application during surgery. Furthermore, the clear gel provides good visibility, aiding surgeons in maintaining precise control during operations. No special storage conditions or mixing is required, allowing for simplified integration into surgical workflows.
About Fziomed, Inc.
Founded in 1996, Fziomed, Inc. has established itself as a pioneer in the field of biomaterials, focusing on the preservation of surgical excellence across various medical domains. The company develops and commercializes surgical biomaterials that significantly enhance postoperative recovery and patient care. Currently, Fziomed's products are available in over 70 countries, and they continue to play a vital role in nearly a million surgical procedures globally.
Innovative Technology for Better Surgical Results
The dual-polymer technology at the heart of Fziomed's adhesion barrier products allows for a temporary, physical separation of tissues during healing, ultimately reducing the formation of adhesions. Healthcare professionals benefit not only from the technology itself but also from the years of proven clinical results that support its efficacy.
Frequently Asked Questions
What is Dynavisc and how does it work?
Dynavisc is an adhesion barrier gel that utilizes a dual-polymer technology to reduce adhesion formation between tissues after surgeries.
When will Fziomed participate in the Global Hand Congress?
Fziomed will showcase its products at the 2025 Global Hand Congress taking place from March 24-28.
How has Fziomed’s technology been received in clinical settings?
Fziomed’s technology has been clinically validated for over 20 years, used in nearly one million procedures worldwide.
Is Dynavisc available in the United States?
Currently, Dynavisc has not yet received FDA clearance for use within the United States.
What are the benefits of using adhesion barrier gels?
Adhesion barrier gels prevent postoperative adhesions, reducing pain and improving postoperative recovery and mobility.
